Clinical Trial Update: A Phase 1b Open-label Study to Evaluate Safety of Plamotamab in Participants With Rheumatoid Arthritis [Phase 1]

View source ↗

Summary

A Phase 1b open-label study to evaluate the safety of Plamotamab in participants with rheumatoid arthritis is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Plamotamab (plamotamab)

Snippet

Sponsor: Xencor, Inc. | Conditions: Rheumatoid Arthritis | Phase 1 | Status: RECRUITING